| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/11/2009 | US7572437 Long acting human interferon analogs |
| 08/11/2009 | US7572436 Thionin as an antineoplastic and immunostimulant |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2289283C Metastasis models using green fluorescent protein (gfp) as a marker |
| 08/11/2009 | CA2287521C Human recombinant beta-interferon with improved solubility |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/11/2009 | CA2236699C Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/11/2009 | CA2192940C Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 08/08/2009 | CA2653300A1 Polyvalent vaccine against salmonid alphavirus infections |
| 08/07/2009 | CA2618163A1 Head and neck cancer biomarkers |
| 08/06/2009 | WO2009097540A1 Methods, compositions, and systems for production of recombinant spider silk polypeptides |
| 08/06/2009 | WO2009097128A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 08/06/2009 | WO2009096916A1 Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
| 08/06/2009 | WO2009096502A1 Marker for depression and depressed state and detection and diagnosis using the same |
| 08/06/2009 | WO2009096304A1 Chemical sensor having sensitive membrane imitating olfactory receptor |
| 08/06/2009 | WO2009095925A2 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 08/06/2009 | WO2009095916A2 Cd14 and peptides thereof for protection of cells against cell death |
| 08/06/2009 | WO2009095857A1 Multimeric proteins able to induce an antibody response against the beta-amyloid and use thereof |
| 08/06/2009 | WO2009095790A1 Preparation of terminally-sterilized collagen that is soluble at neutral ph |
| 08/06/2009 | WO2009095516A1 Metal nanoparticles functionalised with neuropeptide vip and preparation method |
| 08/06/2009 | WO2009095455A1 Plants having increased yield-related traits and a method for making the same |
| 08/06/2009 | WO2009095453A1 Treatment of microbial infections |
| 08/06/2009 | WO2009095452A1 Crystal structure of the atpase domain of proteins of the hsp70 family |
| 08/06/2009 | WO2009095447A1 Muteins of tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
| 08/06/2009 | WO2009095425A1 Liquid enzyme composition |
| 08/06/2009 | WO2009095403A1 Expression system and uses thereof for the production of human long pentraxin 3 |
| 08/06/2009 | WO2009095372A1 Methods and compositions using klotho-fgf fusion polypeptides |
| 08/06/2009 | WO2009095239A1 Three-dimensional structure of the amyloid precursor protein intracellular domain (aicd) in complex with human fe65-ptb2 |
| 08/06/2009 | WO2009095235A1 Methods to stabilize proteins and polypeptides |
| 08/06/2009 | WO2009095059A1 Rubber biosynthesis promoters from taraxacum koksaghyz and their use |
| 08/06/2009 | WO2009094850A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
| 08/06/2009 | WO2009094742A1 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
| 08/06/2009 | WO2009094726A1 Plasmodial polynucleotides, proteins and uses thereof |
| 08/06/2009 | WO2009094719A1 Anti fungal methods |
| 08/06/2009 | WO2009061130A3 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 08/06/2009 | WO2009052242A3 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 08/06/2009 | WO2009052221A3 Methods for extracting platelets and compositions obtained therefrom |
| 08/06/2009 | WO2009051717A3 Human factor ix variants with an extended half life |
| 08/06/2009 | WO2009047002A3 Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 08/06/2009 | WO2009019657A3 Means for diagnosis and treatment of rheumatoid arthritis |
| 08/06/2009 | WO2008112917A8 Peptidyl fluoromethylketones as inhibitors of viral replication |
| 08/06/2009 | WO2008109433A8 Anti-angiogenic peptides |
| 08/06/2009 | WO2008106551A8 Brachyury polypeptides and methods for use |
| 08/06/2009 | WO2008086449A8 Synthetic osteopontin peptides and methods of use |
| 08/06/2009 | WO2008045548A3 Codon optimized cftr |
| 08/06/2009 | WO2008028068A8 NON-HUMAN PRIMATE FCεR1α POLYPEPTIDES |
| 08/06/2009 | WO2008020968A8 Recombinant interferon-beta with enhanced biological activity |
| 08/06/2009 | WO2007115201A8 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 08/06/2009 | WO2005091925A8 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 08/06/2009 | WO2003006626A3 CRYSTAL STRUCTURE OF A MarR FAMILY POLYPEPTIDE |
| 08/06/2009 | US20090199307 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence |
| 08/06/2009 | US20090198043 Feline il-18 proteins |
| 08/06/2009 | US20090198042 Polyvalent vaccine |
| 08/06/2009 | US20090197887 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197809 Antifungal methods |
| 08/06/2009 | US20090197805 Insulin receptor antagonists and related compositions, uses and methods |
| 08/06/2009 | US20090197803 METHODS AND COMPOSITIONS FOR MODULATING T HELPER (Th) CELL DEVELOPMENT AND FUNCTION |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090197801 Neuritogenic peptides |
| 08/06/2009 | US20090197342 measuring the level of pregnancy-associated plasma protein-A (PAPP-A) in a biological sample from a non-pregnant patient and comparing the level with that of control subjects |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090197319 Virus-Like Particle Containing A Dengue Recombinant Replicon |
| 08/06/2009 | US20090197317 TSG-Like Gene |
| 08/06/2009 | US20090197315 Fullerene-based amino acids |
| 08/06/2009 | US20090197311 Method for the production of simvastatin |
| 08/06/2009 | US20090197301 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/06/2009 | US20090197278 Antibodies to hADA2 |
| 08/06/2009 | US20090197271 Functional nucleic acid ligands to fluorescent proteins |
| 08/06/2009 | US20090196927 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor |
| 08/06/2009 | US20090196909 Carbon nanotube containing material for the capture and removal of contaminants from a surface |
| 08/06/2009 | US20090196888 Nucleic acids encoding recombinant 56 and 82 kDa antigents from gametocytes of Eimeria maxima and their uses |
| 08/06/2009 | US20090196886 Vaccine against nicotine addiction |
| 08/06/2009 | US20090196884 Malaria Vaccines |
| 08/06/2009 | US20090196883 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine |
| 08/06/2009 | US20090196882 Methods of producing antibodies to zalpha11 cytokine receptors |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2714387A1 Extracellular matrix compositions |
| 08/06/2009 | CA2713993A1 Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
| 08/06/2009 | CA2713557A1 Muteins of tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
| 08/06/2009 | CA2713358A1 Preparation of terminally-sterilized collagen that is soluble at neutral ph |
| 08/06/2009 | CA2713241A1 Treatment of microbial infections |
| 08/06/2009 | CA2712634A1 Methods and compositions using klotho-fgf fusion polypeptides |
| 08/06/2009 | CA2712432A1 Methods to stabilize single variable domains |
| 08/06/2009 | CA2712336A1 Plants having increased yield-related traits and a method for making the same |
| 08/06/2009 | CA2712290A1 Anti fungal methods |
| 08/06/2009 | CA2711207A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
| 08/06/2009 | CA2699916A1 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 08/05/2009 | EP2085905A1 Protein three-dimensional structure processing system and method and program of processing protein three-dimensional structure |
| 08/05/2009 | EP2085478A1 A long QT syndrome gene which encodes KVLQT1 and its association with minK |
| 08/05/2009 | EP2085476A1 Method of enabling stable expression of transgene |
| 08/05/2009 | EP2085475A1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085468A1 DNA transfection system for the generation of infectious influenza virus |
| 08/05/2009 | EP2085467A2 Lutzomyia Longipalpis polypeptides and methods of use |
| 08/05/2009 | EP2085406A1 Long lasting insulin derivatives and methods thereof |